Aktiesnakken — November 2010
-
genmab nu
-
link
-
Vi forventer, at omsætningen i 2010, inklusive royalties på DKK 55 mio. fra salg af
Arzerra, vil udgøre ca. DKK 575 - 585 mio. sammenlignet -
-
fabrikken nedskrevet yderliger emed 130mio
-
så kom opjusteringen som jeg sagde!
-
forventet salg i 2011
-
driftsunderskuddet for 2010 nedjusteres
-
Vi forventer, at driftsunderskuddet for fortsættende aktiviteter for 2010 vil udgøre
ca. DKK 200 - 250 mio. sammenlignet med tidligere forv -
det er jo opjusteringer? men jeg forstår ikke man tager en nedjustering på fabrikken inden man har solgt
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind